Hazel T. Mufhandu

Mahikeng, NW 2735, South Africa

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Aerosolized mRNA monoclonal antibodies: A new frontier in passive immunization for neonatal foals.

Aerosolized mRNA monoclonal antibodies: A new frontier in passive immunization for neonatal foals.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: July 30, 2025

Synthesis, characterization and antiviral efficacy of valacyclovir loaded polymeric nanoparticles against wild-type herpes simplex virus type 2.

Synthesis, characterization and antiviral efficacy of valacyclovir loaded polymeric nanoparticles against wild-type herpes simplex virus type 2.

Journal: Biomedical materials (Bristol, England)

Published: September 30, 2024

Investigation of mutations in the partial sequences of the surface and polymerase genes of hepatitis B virus associated with immune escape and drug resistance in HIV-infected patients.

Investigation of mutations in the partial sequences of the surface and polymerase genes of hepatitis B virus associated with immune escape and drug resistance in HIV-infected patients.

Journal: F1000Research

Published: September 27, 2023

Current ARTs, Virologic Failure, and Implications for AIDS Management: A Systematic Review.

Current ARTs, Virologic Failure, and Implications for AIDS Management: A Systematic Review.

Journal: Viruses

Published: June 30, 2023

Biomedical applications of biodegradable polycaprolactone-functionalized magnetic iron oxides nanoparticles and their polymer nanocomposites.

Biomedical applications of biodegradable polycaprolactone-functionalized magnetic iron oxides nanoparticles and their polymer nanocomposites.

Journal: Colloids and surfaces. B, Biointerfaces

Published: March 08, 2023

Next-Generation Vaccines: Nanovaccines in the Fight against SARS-CoV-2 Virus and beyond SARS-CoV-2.

Next-Generation Vaccines: Nanovaccines in the Fight against SARS-CoV-2 Virus and beyond SARS-CoV-2.

Journal: BioMed research international

Published: December 27, 2022

Potential of Azadirachta indica as a Capping Agent for Antiviral Nanoparticles against SARS-CoV-2.

Potential of Azadirachta indica as a Capping Agent for Antiviral Nanoparticles against SARS-CoV-2.

Journal: BioMed research international

Published: June 06, 2022

Seroprevalence and characterisation of herpes simplex virus from human immunodeficiency virus in samples collected from two provinces in South Africa: a retrospective study.

Seroprevalence and characterisation of herpes simplex virus from human immunodeficiency virus in samples collected from two provinces in South Africa: a retrospective study.

Journal: F1000Research

Published: November 15, 2021

Applications of Nanoparticles for Herpes Simplex Virus (HSV) and Human Immunodeficiency Virus (HIV) Treatment.

Applications of Nanoparticles for Herpes Simplex Virus (HSV) and Human Immunodeficiency Virus (HIV) Treatment.

Journal: Journal of biomedical nanotechnology

Published: June 04, 2021

Synthesis of fluorescence labelled aptamers for use as low-cost reagents in HIV/AIDS research and diagnostics.

Synthesis of fluorescence labelled aptamers for use as low-cost reagents in HIV/AIDS research and diagnostics.

Journal: Biomedical reports

Published: June 01, 2021

Progress and Perspectives on HIV-1 microbicide development.

Progress and Perspectives on HIV-1 microbicide development.

Journal: Virology

Published: June 12, 2016

UCLA1 aptamer inhibition of human immunodeficiency virus type 1 subtype C primary isolates in macrophages and selection of resistance.

UCLA1 aptamer inhibition of human immunodeficiency virus type 1 subtype C primary isolates in macrophages and selection of resistance.

Journal: Biochemistry and biophysics reports

Published: February 16, 2016

Showing 1-12 of 13

Last Updated: 09/26/2026